The Synthesis and in Vitro and in Vivo Stability of 5-Fluorouracil Prodrugs Which Possess Serum Albumin Binding Potency.

Authors:
  • KSKenji Shimidzu
    Kenji Shimidzu
  • MSMasao Sumi
    Masao Sumi
  • NONaoto Oku
    Naoto Oku
  • SKShoichi Kusumoto
    Shoichi Kusumoto
  • TNTanekazu Nadai
    Tanekazu Nadai
  • SYShinji Yamashita
    Shinji Yamashita

Abstract
For a new drug delivery system of 5-fluorouracil, we prepared prodrugs possessing certain desired properties. The prodrugs, 1-(N-4-chlorophenyl-N-methylcarbamoyl)-5-fluorouracil and 1-(N-2,4-dichlorophenyl-N-methylcarbamoyl)-5-fluorouracil, contain high serum albumin binding potency and a comparably long half life in the bloodstream in vivo to Tegafur. These two prodrugs are expected to be retained in the bloodstream as a polymeric complex with albumin and to circulate in the body for a long time, like a polymeric prodrug.